Application of multimodal ultrasound in intraoperative evaluation of brain tumor

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073855

Enrollment

Unknown

Registered

2023-07-24

Start date

2023-05-19

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumors

Interventions

Experimental group:Multimodal ultrasound

Eligibility

Sex/Gender

All

Age

16 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed as brain tumors by CT and enhanced MRI in our hospital and eligible for brain tumor surgery; (2) Age range from 16 to 80 years old; (3) Voluntarily choose to undergo surgery under intraoperative ultrasound guidance and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Previous other treatments, such as radiotherapy, chemotherapy and brain tumor surgery; (2) Patients with coagulation dysfunction and severe diseases such as the brain, heart, and liver that cannot undergo brain tumor surgery; (3) Allergies to ultrasound contrast agents

Design outcomes

Primary

Measure	Time frame
B-mode ultrasound;Elastography;Contrast-enhanced ultrasound;Color Doppler flow image ( CDFI);Fine blood flow;	—

Countries

China

Contacts

Public ContactMan Lu

Sichuan Cancer Hospital

graceof@163.com+86 189 8183 8950

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026